SEB Asset Management AB Takes $4.03 Million Position in Astera Labs, Inc. $ALAB

SEB Asset Management AB bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 36,730 shares of the company’s stock, valued at approximately $4,026,000.

Other institutional investors have also bought and sold shares of the company. Reflection Asset Management purchased a new position in shares of Astera Labs during the 4th quarter valued at $25,000. Smartleaf Asset Management LLC increased its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs in the fourth quarter worth $33,000. Whipplewood Advisors LLC raised its holdings in shares of Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after acquiring an additional 319 shares in the last quarter. Finally, Assetmark Inc. lifted its position in Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after purchasing an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the business’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total transaction of $270,997.44. Following the sale, the director owned 5,550 shares in the company, valued at approximately $2,192,472. This trade represents a 11.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,676,845 shares of company stock valued at $444,928,806 over the last 90 days. 10.40% of the stock is currently owned by company insiders.

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $330.89 on Thursday. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The stock has a market capitalization of $56.72 billion, a P/E ratio of 223.57, a P/E/G ratio of 3.70 and a beta of 3.66. The company’s 50-day moving average is $355.80 and its 200 day moving average is $224.15.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same period last year, the business posted $0.33 earnings per share. Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts anticipate that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of recent research reports. Barclays boosted their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday. Bank of America upped their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Morgan Stanley increased their price objective on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Finally, Evercore restated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $282.00.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.